Telmisartan and stroke reduction in the ONTARGET trial: Benefit beyond blood pressure lowering?

Victor L. Serebruany; Dan Atar; Dan F. Hanley

doi:10.1159/000164555

Telmisartan and stroke reduction in the ONTARGET trial: Benefit beyond blood pressure lowering?

Victor L. Serebruany, Dan Atar, Dan F. Hanley

School of Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	563-564
Number of pages	2
Journal	Cerebrovascular Diseases
Volume	26
Issue number	5
DOIs	https://doi.org/10.1159/000164555
State	Published - Nov 2008

ASJC Scopus subject areas

Neurology
Clinical Neurology
Cardiology and Cardiovascular Medicine

Access to Document

10.1159/000164555

Cite this

@article{d5eee379f51d4255a79558b1acb029f6,

title = "Telmisartan and stroke reduction in the ONTARGET trial: Benefit beyond blood pressure lowering?",

author = "Serebruany, {Victor L.} and Dan Atar and Hanley, {Dan F.}",

year = "2008",

month = nov,

doi = "10.1159/000164555",

language = "English (US)",

volume = "26",

pages = "563--564",

journal = "Cerebrovascular Diseases",

issn = "1015-9770",

publisher = "S. Karger AG",

number = "5",

}

TY - JOUR

T1 - Telmisartan and stroke reduction in the ONTARGET trial

T2 - Benefit beyond blood pressure lowering?

AU - Serebruany, Victor L.

AU - Atar, Dan

AU - Hanley, Dan F.

PY - 2008/11

Y1 - 2008/11

UR - http://www.scopus.com/inward/record.url?scp=53949125743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53949125743&partnerID=8YFLogxK

U2 - 10.1159/000164555

DO - 10.1159/000164555

M3 - Article

C2 - 18936537

AN - SCOPUS:53949125743

SN - 1015-9770

VL - 26

SP - 563

EP - 564

JO - Cerebrovascular Diseases

JF - Cerebrovascular Diseases

IS - 5

ER -

Telmisartan and stroke reduction in the ONTARGET trial: Benefit beyond blood pressure lowering?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this